Skip to content
10-Q

Quarterly Report

TG THERAPEUTICS, INC. TGTX

0001437749-24-033948

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 4, 2024 155.67M sh
Long Term Debt Q3 2024 · Sep 30, 2024 $244.16M
Long Term Debt Q3 2024 · Dec 31, 2023 $100.12M
Short Term Investments Q3 2024 · Sep 30, 2024 $145.22M
Short Term Investments Q3 2024 · Dec 31, 2023 $124.58M
Current Liabilities Q3 2024 · Sep 30, 2024 $125.11M
Current Liabilities Q3 2024 · Dec 31, 2023 $53.72M
Total Liabilities Q3 2024 · Sep 30, 2024 $393.86M
Total Liabilities Q3 2024 · Dec 31, 2023 $169.09M
Current Assets Q3 2024 · Sep 30, 2024 $574.07M
Current Assets Q3 2024 · Dec 31, 2023 $317.94M
Total Assets Q3 2024 · Sep 30, 2024 $586.01M
Total Assets Q3 2024 · Dec 31, 2023 $329.59M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $92.93M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $150.9M
Shares Diluted Q3 2024 · Sep 30, 2023 155.87M sh
Shares Diluted Q3 2024 · Sep 30, 2023 145.95M sh
Capex Q3 2024 · Sep 30, 2023 $0
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$18.2M
Stockholders Equity Q3 2024 · Sep 30, 2023 $164.77M
Stockholders Equity Q3 2024 · Jun 30, 2023 $40.45M
Stockholders Equity Q3 2024 · Mar 31, 2023 $27.43M
Stockholders Equity Q3 2024 · Dec 31, 2022 $58.59M
Eps Diluted Q3 2024 · Sep 30, 2023 $0.73
Eps Diluted Q3 2024 · Sep 30, 2023 $0.19
Eps Basic Q3 2024 · Sep 30, 2023 $0.80
Eps Basic Q3 2024 · Sep 30, 2023 $0.19
Sga Expense Q3 2024 · Sep 30, 2023 $32.77M
Sga Expense Q3 2024 · Sep 30, 2023 $91.55M
Rd Expense Q3 2024 · Sep 30, 2023 $14.75M
Rd Expense Q3 2024 · Sep 30, 2023 $58.74M
Net Income Q3 2024 · Sep 30, 2023 $113.93M
Net Income Q3 2024 · Sep 30, 2023 $27.09M
Net Income Q3 2024 · Jun 30, 2023 −$47.61M
Net Income Q3 2024 · Mar 31, 2023 −$39.23M
Operating Income Q3 2024 · Sep 30, 2023 $114.78M
Operating Income Q3 2024 · Sep 30, 2023 $33.12M
Revenue Q3 2024 · Sep 30, 2023 $165.82M
Revenue Q3 2024 · Sep 30, 2023 $189.69M